In 2020, many countries adapted and expanded differentiated service delivery (DSD) for HIV treatment to meet the challenges raised by the COVID-19 pandemic. Around the world, countries released interim policies expanding eligibility for DSD, antiretroviral therapy (ART) refills and prescriptions and recommending community-based models.

These dashboards were created by the DSD programme at the IAS – International AIDS Society to summarize key elements of national DSD treatment policies, including the available policy responses to the COVID-19 pandemic. They convey policy information in a quick and easy-to-understand graphic format.

Access national HIV policies related to DSD here, or view our COVID-19 pages for national and global policies on COVID-19 related DSD adaptations, as well as other useful resources.

Click on the ovals in the table to access the referenced policy, or download the PDF with fully hyperlinked reference list.  

Please note that these dashboards are beta versions, we welcome feedback and comments to [email protected].

Dashboards-full-report-Jan22Web

Report: National policy dashboards of differentiated service delivery for HIV treatment

This report summarizes all the DSD dashboards presented below

1-Time-to-DSD-Eligibility-Jan22

DSD Dashboard: Time on ART before eligible for DSD for HIV treatment

This dashboard indicates the minimum duration an eligible client must be on antiretroviral therapy (ART) before inclusion in a country’s DSD model

2-Regimens-eligible-in-DSD-Jan22

DSD Dashboard: Regimens eligible in DSD for HIV treatment

This dashboard shows which ART regimens are eligible for inclusion in DSD treatment models according to country

3-max-duration-of-art-refils-Jan22

DSD Dashboard: Maximum duration of ART refills for adults within DSD for HIV treatment

This dashboard summarizes national policy on the maximum ART refill length for eligible adults within DSD models

4-art-refill-length-Jan22

DSD Dashboard: DSD ART refill length by age group

This dashboard summarises national policies on DSD ART refill length by age group

5-Frequency-of-clinical-consultations-Jan22

DSD Dashboard: Frequency of clinical consultations among those in DSD for HIV treatment models

This dashboard visualizes national policies on the frequency of clinical consultations within DSD for HIV treatment models

6-Eligiblility-in-Children-Jan22

DSD Dashboard: Eligibility of children (0-14 years) in DSD for HIV treatment

This dashboard indicates national policy on the categories of children eligible for DSD for HIV treatment

7-Eligibility-of-PBFW-Jan22

DSD Dashboard: Eligibility for pregnant and breastfeeding women in DSD for HIV treatment

This dashboard summarises national policies on inclusion of pre and post natal women in DSD HIV treatment models

8-Eligibility-of-adolescents-Jan22

DSD Dashboard: Eligibility of older adolescents (15-18yrs) in DSD for HIV treatment

This dashboard summarises national policies on inclusion of older adolescents in DSD for HIV treatment

10-Integration-with-TPT-Jan22

DSD Dashboard: Integration of TB preventive therapy (TPT) within DSD for HIV treatment models

This dashboard summarises national policies on integration of TB preventive therapy (TPT) withint DSD for HIV treatment models

11-Integration-with-NCD-Refills-with-DSD-Jan22

DSD Dashboard: Integration of non-communicable disease refills within DSD for HIV treatment models

This dashboard summarises national policies on integration of non-communicable disease refulls within DSD for HIV treatment models

12-Integration-with-FP-commodities-with-DSD-Jan22

DSD Dashboard: Integration of family planning within DSD for HIV treatment models

This dashboard summarises national policies on integration of family planning within DSD for HIV treatment models

DSD Dashboard: Group models of DSD for HIV treatment

This dashboard summarises national policies on group models of DSD for HIV treatment

15-Community-models-June2021-WEB

DSD Dashboard: Community models of DSD for HIV treatment

This dashboard summarises national policies on community models of DSD for HIV treatment